# BayOmics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/bayomics

- Industry: Biotechnology
- Headquarters: Shenzhen, China
- Website: www.bayomics.com
- Latest round: Angel (Apr 26, 2022)
- Investors on record: 1

## About

Based in Shenzhen, China and founded in 2022, Shenzhen BayOmics Biotechnology Co., Ltd., trading under the name BayOmics, is a biotech company that focuses on the research and development of proteomics products used for disease diagnosis and innovative drug discovery.

In October 2025, BayOmics closed pre-series A+ funding from new investor Xietong Investment. In December 2025, the company continued to complete pre-series A++ funding from returning investor Xietong Investment.

BayOmics's main products include SISPROT, a series of proteomics sample preparation kits that can stably detect about 6,000 proteins with an initial sample volume of 100 ng through one-stop sample pretreatment, and proteomics solutions such as spatial visualization proteomics solutions and cell type proteomics solutions. The products are applied for studying proteins in biopharmaceutical discovery. The company generates revenue from developing and sales of proteomics kits and solutions.

The pre-series A++ funding will be used by the company to advance its technology research and development and expand its drug pipeline, further strengthening its competitiveness in the field of precision medicine.

## Funding rounds

- Angel, Apr 26, 2022 — GL Ventures

## Investors

- GL Ventures (https://capitalatlas.ai/funds/gl-ventures) — Angel